6-33780115-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_181336.4(LEMD2):āc.995A>Gā(p.Lys332Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000433 in 1,592,532 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0020 ( 1 hom., cov: 32)
Exomes š: 0.00026 ( 1 hom. )
Consequence
LEMD2
NM_181336.4 missense
NM_181336.4 missense
Scores
1
6
11
Clinical Significance
Conservation
PhyloP100: 3.35
Genes affected
LEMD2 (HGNC:21244): (LEM domain nuclear envelope protein 2) This gene encodes a LEM domain-containing transmembrane protein of the inner nuclear membrane. The protein is involved in nuclear structure organization and plays a role in cell signaling and differentiation. Mutations in this gene result in Cataract 46, juvenile-onset. Multiple transcript variants have been found for this gene. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006903559).
BP6
Variant 6-33780115-T-C is Benign according to our data. Variant chr6-33780115-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2042860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LEMD2 | NM_181336.4 | c.995A>G | p.Lys332Arg | missense_variant | 5/9 | ENST00000293760.10 | |
LEMD2 | NM_001348710.2 | c.596A>G | p.Lys199Arg | missense_variant | 5/9 | ||
LEMD2 | NM_001143944.1 | c.89A>G | p.Lys30Arg | missense_variant | 4/8 | ||
LEMD2 | NM_001348709.2 | c.89A>G | p.Lys30Arg | missense_variant | 5/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LEMD2 | ENST00000293760.10 | c.995A>G | p.Lys332Arg | missense_variant | 5/9 | 1 | NM_181336.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00203 AC: 309AN: 152212Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
309
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000572 AC: 125AN: 218640Hom.: 0 AF XY: 0.000451 AC XY: 53AN XY: 117506
GnomAD3 exomes
AF:
AC:
125
AN:
218640
Hom.:
AF XY:
AC XY:
53
AN XY:
117506
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000264 AC: 380AN: 1440202Hom.: 1 Cov.: 30 AF XY: 0.000210 AC XY: 150AN XY: 714188
GnomAD4 exome
AF:
AC:
380
AN:
1440202
Hom.:
Cov.:
30
AF XY:
AC XY:
150
AN XY:
714188
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00203 AC: 309AN: 152330Hom.: 1 Cov.: 32 AF XY: 0.00199 AC XY: 148AN XY: 74482
GnomAD4 genome
AF:
AC:
309
AN:
152330
Hom.:
Cov.:
32
AF XY:
AC XY:
148
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
30
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
75
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
LEMD2-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jul 03, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;D
REVEL
Benign
Sift
Benign
T;.;T;D
Sift4G
Pathogenic
D;D;T;.
Polyphen
D;D;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at